<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inherited <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> are thought to play an important role in the cause of <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> and its recurrence </plain></SENT>
<SENT sid="1" pm="."><plain>Ninety of 281 patients objectively diagnosed as <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> between 2006 and 2009 were included in the study </plain></SENT>
<SENT sid="2" pm="."><plain>The screening for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> included mutations of factor V Leiden (FVL), prothrombin (PTM) G20210A, <z:chebi fb="13" ids="29357,29358">methylene</z:chebi> <z:chebi fb="0" ids="20506,26907">tetrahydrofolate</z:chebi> reductase C677T-A1298C, the serum levels of antithrombin III, protein C, protein S, factor VIII and activated protein C resistance </plain></SENT>
<SENT sid="3" pm="."><plain>Forty-two male (46.7%) and 48 female (53.3%) patients had a mean age of 62.6 ± 13.4 years </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with common <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> comprised 30% of <z:hpo ids='HP_0000001'>all</z:hpo> cases (FVL: 19.1%, PTM G20210A: 3.4%, <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo>: 1.1%, <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo>: 5.7%, <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e>: 13.6%) </plain></SENT>
<SENT sid="5" pm="."><plain>A significant association between recurrence of <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> (10 patients, 12.2%) and <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> was established (P = 0.040) </plain></SENT>
<SENT sid="6" pm="."><plain>Serum level of protein C was also significantly lower in the subgroup of recurrent <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> (P = 0.049) </plain></SENT>
<SENT sid="7" pm="."><plain>FVL and PTM mutations were high in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients; the presence of inherited <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> was low with risk factors of surgery and immobilization </plain></SENT>
<SENT sid="8" pm="."><plain>Genetic risk factors were high in patients with <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Protein C and S deficiencies may play a role in <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> recurrence </plain></SENT>
<SENT sid="10" pm="."><plain>DVT or family history of <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> was not found to be related to inherited <z:hpo ids='HP_0100724'>thrombophilias</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Surgery and immobilization were thought not to have priorities for detection of genetic risk factors </plain></SENT>
<SENT sid="12" pm="."><plain>The high percentages of FVL and PTM mutations in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients should be considered </plain></SENT>
</text></document>